Thursday, August 16, 2018
 
 
Company News: Page (1) of 1 - 05/25/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Indivior Announces Regulatory Submission to Australia's Therapeutic Goods Administration (TGA) for SUBLOCADE™ (Buprenorphine Extended-Release) Injection for the Treatment of Opioid Dependence
 
(May 25, 2018)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:Canada,USA, Inc.,Medicine,Disease,healthcare,Therapy,Surgery,Science,Medical,Business,Other,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines